Ladarixin

ladarixin · Dompé Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ladarixin, covering 2022-01-11 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Ladarixin With Sotorasib in Advanced NSCLC [Phase 1]